arrow
S

Sharlene Gill

BC Cancer
H指数:41
被引数:7,790

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Report from the 27th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Calgary, Alberta, 26–27 September 2025: Advances in Colon and Rectal Cancer

第27届加拿大西部胃肠肿瘤共识会议(阿尔伯塔省卡尔加里,2025年9月26-27日)关于结直肠癌的报告:结直肠癌领域的进展

2026-07-230
OA
Canadian National Pancreas Conference 2025: Recent Advances in Patient-Centred Management of Pancreatic Cancer

2025年加拿大全国胰腺大会:胰腺癌以患者为中心管理的最新进展

2026-01-010
OA
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial

循环肿瘤DNA指导的辅助治疗在局部晚期结肠癌中的应用:随机II/III期DYNAMIC-III试验

2025-10-200
PRE
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

Terry Fox Research Institute马拉松希望癌症中心网络:一项全加拿大的精准肿瘤学倡议

2025-04-010
PRE
Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts

标准化辅助结肠癌试验中的数据收集: IDEA和ACCENT国际财团和国家专家的共识项目

2024-07-010
OA
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
2023-06-0162
OAAI
The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma

CCTG PA.7吉西他滨和nab-紫杉醇联合或不联合durvalumab和tremelimumab作为转移性胰腺导管腺癌初始治疗的II期试验

2022-08-2657
OAAI